Yahoo Web Search

Search results

    • FDA Panel Rejects MDMA Drug for PTSD

      Medscape· 4 days ago

      A US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for the treatment of ...

    • BriaCell Presents Clinical Efficacy Data at ASCO 2024

      Digital Journal· 5 days ago

      BriaCell doubles Progression-Free-Survival (PFS) and Clinical Benefit Rate vs historical results in the literatureBria-IMT™ PFS compares favorably to PFS of most recent treatment in 48% of Antibody-Drug ...

    • Small Business - Salisbury Post | Salisbury Post

      The Salisbury Post· 5 days ago

      UNION therapeutics announces successful completion of the ADESOS Phase 2b study and presentation of data at the RAVE Conference 2024 PR Newswire HELLERUP, Denmark, June 4, 2024 ADESOS Phase 2b study evaluating orismilast as an oral treatment in

    • Small Business - Salisbury Post | Salisbury Post

      The Salisbury Post· 4 days ago

      SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and